MYEC Stock Alert 08/17/2014 06:18:43 $MYEC That seems to

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
MYEC Stock Alert 08/17/2014 06:18:43 $MYEC

That seems to be the only way this one will produce money...there won't be any long term sustained drives. Not with nearly 4billion shares out...
beautiful, in time my friend. IN TIME! Share holders meeting will be the best!
Long in MYEC is a wise position Nit! :^)
The patent wasn't worthless. The patent was the reason the bankruptcy was dismissed in the first place...
(MYEC)"Licensing fees are beastly"-made BillGates super rich!!!


AGAIN!!! :^) :^) :^)
Buybacks/increased pps will (both)elevate book value nicely(with time)! :^)
If true, we are taking off for a huge run here!
$32,381X4 = $129,524/4,177,470,000 = .00003 book value.
Lemme see...fell 99.9%, then rebounded 10,000%!(MathTime!!!!) ;&
This one fell 99.9% What a winner huh.
so the quarterlies were reduced a bit.. lets look at the big picture, our first full fiscal year of financials will be great

Imagine we sign another 3 clients before Jan 1st

it will be a 3 million dollar year

Imagine we sign 10 new clients


LOLS


Licensing fees are beastly, we just need a few more clients
LMAO!!! Most Nasdaq tickers move up 1%/month!!!!!!!!!
FORTUNATELY, it's nearing end...with NO (more)loans out!!! :^)
Awe, shucks. Those pesky conversions.

Too bad this can't make enough money not to sell paper.

You know like a NASDAQ ticker. WEEEEEEEEEEEEEEEEEEEEEEEEEE
Unfortunately, 400million conversion came shortly after causing downtrend! ;^/
Is that why there was a 90%+ reduction in profits from Q2 2013 to Q2 2014?

You know, because it is so amazing and all.
"MyEcheck was substantially reliant on these agreements for its business."
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Palisade Bio Launches PALI-2108 Study to Combat Crohn’s Disease

Updated Category News Views 142

Exciting Developments in Crohn’s Disease Treatment Today marks a pivotal point as Palisade Bio, Inc. (NASDAQ: PALI), a dynamic clinical-stage biopharmaceutical firm, undertakes a groundbreaking step in medical research by announcing the commencement of patient dosing in their Phase 1b clinical trial. This study is focused on PALI-2108, a novel therapeutic designed...

Continue Reading
Discover How Your $100 Investment in TD Synnex Has Grown

Updated Category News Views 126

Understanding the Growth of Your Investment in TD Synnex Investing in stocks can often feel like navigating a complex maze, especially when evaluating potential growth over time. One standout in the tech industry is TD Synnex (NASDAQ: SNX), a company that has consistently outperformed benchmark indices. Over the past five years, TD Synnex has achieved an annualized return...

Continue Reading
Castor Maritime Inc. Completes Successful Sale and Leaseback

Updated Category News Views 170

Castor Maritime Inc. Completes Successful Sale and Leaseback Castor Maritime Inc. (NASDAQ: CTRM), a versatile player in the global shipping and energy sector, recently announced an exciting development. The company successfully concluded a significant sale and leaseback transaction for its vessel, the M/V Magic Thunder, an impressive Kamsarmax bulk carrier that was built...

Continue Reading
Yamaha's Partnership with Locally Enhances Dealer Collaboration

Updated Category News Views 153

Yamaha Expands Dealer Network with Innovative Omnichannel Solutions Yamaha, a renowned global leader in musical instruments and audio solutions, has recently announced a strategic partnership with Locally. This collaboration aims to elevate the shopping experience for consumers and to strengthen relationships with local retailers. This initiative is particularly...

Continue Reading
POET Technologies Celebrates AI Award Win at Global Tech Awards

Updated Category News Views 73

POET Technologies' Landmark Achievement in Artificial Intelligence POET Technologies Inc. (TSX Venture: PTK; NASDAQ: POET), known for its groundbreaking work with the POET Optical Interposer™, has recently been honored with the title of "Best in Artificial Intelligence" at the Global Tech Awards 2024. This prestigious recognition was announced following the awards...

Continue Reading